General Information of the Compound
Compound ID
CP0545558
Compound Name
3-[3-(4-benzhydrylidenepiperidin-1-yl)propyl]-1H-benzimidazol-2-one
    Show/Hide
Structure
Formula
C28H29N3O
Molecular Weight
423.56
Canonical SMILES
O=c1[nH]c2ccccc2n1CCCN1CCC(CC1)=C(c1ccccc1)c1ccccc1
    Show/Hide
InChI
InChI=1S/C28H29N3O/c32-28-29-25-14-7-8-15-26(25)31(28)19-9-18-30-20-16-24(17-21-30)27(22-10-3-1-4-11-22)23-12-5-2-6-13-23/h1-8,10-15H,9,16-21H2,(H,29,32)
    Show/Hide
InChIKey
QOJZWEYALATGKI-UHFFFAOYSA-N
Physicochemical Property
logP
5.3176
Rotatable Bonds
6
Heavy Atom Count
32
Polar Areas
41.03
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Complexity
32

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 168284879
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01449, P2X purinoceptor 7
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000186 RPMI-8226 Homo sapiens (Human)  1
1
IC50 = 2400 nM
   TI
   LI
   LO
   TS